Guasteferro Danalynn MD is categorized under Podiatrists in Birmingham, AL and active since 2013.
Guasteferro Danalynn MD was established in 2013, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Podiatrists business, which does work in the B2C market, and is classified as a Podiatrists, under code number 6213910 by the NAICS.
If you are seeking more information, feel free to contact Danalynn Guasteferro at the company’s single location by writing to 833 Saint Vincents Drive # 503, Birmingham, Alabama AL 35205 or by phoning (205) 933-4421. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Guasteferro Danalynn MD |
| Contact Person: | Danalynn Guasteferro |
| Address: | 833 Saint Vincents Drive # 503, Birmingham, Alabama 35205 |
| Phone Number: | (205) 933-4421 |
| Website Address: | southviewmedical.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Podiatrists |
| SIC Code: | 8043 |
| NAICS Code: | 6213910 |
| Share This Business: |
Guasteferro Danalynn MD was started in 2013 to provide professional Podiatrists under the SIC code 8043 and NAICS code 6213910. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Danalynn Guasteferro for inquiries that concern Guasteferro Danalynn MD by calling the company number (205) 933-4421, as your correspondence is most welcome. Additionally, the physical location of the single location of Guasteferro Danalynn MD can be found at the coordinates 33.50859,-86.78856 as well as the street address 833 Saint Vincents Drive # 503 in Birmingham, Alabama 35205.
For its online presence, you may visit Guasteferro Danalynn MD’s website at southviewmedical.com and engage with its social media outlets through on Twitter and on Facebook.